SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-082174
Filing Date
2021-03-16
Accepted
2021-03-16 08:02:59
Documents
5
Effectiveness Date
2021-03-16

Document Format Files

Seq Description Document Type Size
1 S-8 d227846ds8.htm S-8 41752
2 EX-5.1 d227846dex51.htm EX-5.1 5522
3 EX-23.1 d227846dex231.htm EX-23.1 1764
4 GRAPHIC g227846dsp07.jpg GRAPHIC 8356
5 GRAPHIC g227846dsp07a.jpg GRAPHIC 7700
  Complete submission text file 0001193125-21-082174.txt   72656
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254320 | Film No.: 21743678
SIC: 2834 Pharmaceutical Preparations